Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Q32 Bio (QTTB) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to $188000.0.

  • Q32 Bio's Other Non Operating Income fell 8457.75% to $188000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 6404.24%. This contributed to the annual value of $4.1 million for FY2024, which is 30322.58% up from last year.
  • According to the latest figures from Q3 2025, Q32 Bio's Other Non Operating Income is $188000.0, which was down 8457.75% from -$318000.0 recorded in Q2 2025.
  • Q32 Bio's 5-year Other Non Operating Income high stood at $131.3 million for Q1 2022, and its period low was -$318000.0 during Q2 2025.
  • Over the past 5 years, Q32 Bio's median Other Non Operating Income value was $358000.0 (recorded in 2024), while the average stood at $7.5 million.
  • As far as peak fluctuations go, Q32 Bio's Other Non Operating Income skyrocketed by 34537631.58% in 2022, and later tumbled by 11330.54% in 2025.
  • Quarter analysis of 5 years shows Q32 Bio's Other Non Operating Income stood at $1.2 million in 2021, then grew by 22.47% to $1.5 million in 2022, then plummeted by 86.53% to $196000.0 in 2023, then surged by 82.65% to $358000.0 in 2024, then crashed by 47.49% to $188000.0 in 2025.
  • Its Other Non Operating Income stands at $188000.0 for Q3 2025, versus -$318000.0 for Q2 2025 and $1.2 million for Q1 2025.